$5.87M
1M
0.28%
$0
Daniel Loeb's position in Silverback Therapeutics is currently worth $5.87M. That's 0.28% of their equity portfolio (28th largest holding). The investor owns 1.07% of the outstanding Silverback Therapeutics stock.
Easily embed the chart on your blog or website – it will always update automatically!
To improve your user experience we use cookies. Privacy Policy
Necessary for the website to function.
Help us understand how you use our site.
Used to show relevant ads.